Digital Science & SciBite Join Forces To Harness Big Data For Life Sciences
LONDON, March 25, 2013 /PRNewswire/ --
Partners to combine text mining and data integration offerings to improve scientific research online
Digital Science, a technology company that provides software tools designed for scientists by scientists and SciBite, a scientific news and alerts service for human health and drug discovery, have signed a two-year collaboration agreement to work together on improving online research for the life sciences.
The agreement gives them access to each other's content and text mining technologies and will provide a connected approach to scientific research, starting with drug discovery and then expanding to other areas of the life sciences.Initially, the two companies will offer their biological and chemical direct data products side-by-side to provide answers to questions like "What are the hottest new targets in a particular disease? Who is working on them and what small molecules have been disclosed in the literature, patents and beyond?" The new partners will also explore ways to integrate the biology and data integration technologies and content of SciBite with that of Digital Science's SureChem suite of patent chemistry products. This will create powerful new solutions and enhance existing offerings from across the Digital Science portfolio. Timo Hannay, Managing Director of Digital Science said, "There is enormous potential in this partnership - we have the opportunity to correlate information from both chemical and biological data sources to speed up scientific research. This supports our goal of developing products that focus on the intersection of chemistry and biology. The social media aspect of SciBite, providing views of the top articles being read by scientific peers, also complements other Digital Science products and services." Lee Harland, founder of SciBite said, "SciBite was founded to open up biomedical intelligence to a wider audience. By partnering with Digital Science we now have a way to connect the unique coverage of chemistry within SureChem to this rich biomedical data, and provide customers with a truly unique view of drug discovery and other life science research areas." Notes to editors:
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV